This company has been acquired
Salud financiera de hoja de balance de Aerie Pharmaceuticals
Salud financiera controles de criterios 2/6
Información clave
-190.6%
Ratio deuda-patrimonio
US$312.59m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$172.46m |
| Patrimonio | -US$163.98m |
| Total pasivo | US$539.57m |
| Activos totales | US$375.59m |
Actualizaciones recientes sobre salud financiera
Recent updates
Alcon to acquire Aerie Pharmaceuticals at ~$770M, enhancing its ophthalmic pharmaceutical portfolio
Aug 23Aerie Pharmaceuticals grants 16.9K stock options
Aug 15Aerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise sales
Aug 05Aerie Pharma completes enrollment in first Phase 3 trial of netarsudil in Japan
Jun 17Aerie Pharmaceuticals, Inc.'s (NASDAQ:AERI) Path To Profitability
Feb 27
Who Has Been Selling Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Shares?
Jan 28Aerie Pharmaceuticals receives European approval for Roclanda
Jan 11Aerie Pharmaceuticals (NASDAQ:AERI) Share Prices Have Dropped 76% In The Last Three Years
Dec 24Is Aerie Pharmaceuticals (NASDAQ:AERI) A Risky Investment?
Nov 28
European advisory group backs Aerie Pharma's Roclanda
Nov 13Análisis de la situación financiera
Pasivos a corto plazo: AERI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: AERI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: AERI has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: AERI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Whilst unprofitable AERI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Pronóstico de cash runway: AERI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 13.9% per year.